文献速递白血病

幼年型粒单核细胞白血病患者的临床与分子特征分析

Clinical and molecular characterization of patients with juvenile myelomonocytic leukaemia.
PubMed 文献 · Br J Haematol · 2025-08-31

该研究对2009至2022年间在埃及接受治疗的81例幼年型粒单核细胞白血病(JMML)患者进行分子分型,发现二代测序(NGS)较传统Sanger测序提高了分子诊断率,NGS和DNA甲基化分析可识别复发高风险患者,并据此构建了可能有助于优先安排造血干细胞移植的风险分层模型。

要点

  • NGS较传统Sanger测序提高了JMML患者的分子诊断数量。
  • 存在多突变或中等/高甲基化分别提示复发风险较高。
  • 联合突变负荷、细胞遗传学和甲基化亚组构建的风险分层模型可能有助于优先安排造血干细胞移植。

核心结论

  • 先进的分子检测对于实现JMML的准确诊断和预测结局至关重要。

研究设计与样本

  • 对2009年至2022年间在埃及接受治疗的81例JMML患者进行分子分型分析。

主要发现

  • NGS较传统Sanger测序增加了具有分子诊断的患者数量。
  • NGS和DNA甲基化分析分别根据存在多突变或中等/高甲基化识别出复发风险较高的患者。
  • 将突变负荷、细胞遗传学和甲基化亚组相结合,开发了一个可能有助于优先安排患者进行造血干细胞移植的风险分层模型。

临床怎么用

  • 作者认为,先进的分子检测是JMML准确诊断和预测结局的关键。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Juvenile myelomonocytic leukaemia (JMML) is a rare haematological malignancy caused by mutations in the Ras signalling pathway. Next-generation sequencing (NGS) and DNA methylation profiling used for diagnostic and risk stratification purposes are now standard of care in Europe and the United States for patients with JMML. To better understand how implementing these types of technologies would impact the treatment of JMML patients in different settings, molecular profiling was performed on 81 patients treated for JMML in Egypt from 2009 to 2022. NGS increased the number of patients with a molecular diagnosis compared to conventional Sanger sequencing. NGS and DNA methylation analysis also identified patients with a higher risk for relapse based on the presence of multiple mutations or intermediate/high methylation respectively. Mutational burden, cytogenetics and methylation subgrouping were combined to develop a risk stratification model that may help to prioritize patients for haematopoietic stem cell transplantation. In summary, advanced molecular testing is key to enabling an accurate diagnosis and predicting outcome in JMML.

来源:Br J Haematol,查看原文。版权归原作者所有。

引用

  1. Meyer JA, Xirenayi S, Werner J, et al. Clinical and molecular characterization of patients with juvenile myelomonocytic leukaemia. Br J Haematol. 2025. PMID: 40887320. doi:10.1111/bjh.70106

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。